Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-38792

Mueller, R J; Stüssi, G; Puga Yung, G; Nikolic, M; Soldini, D; Halter, J; Meyer-Monrad, S; Gratwohl, A; Passweg, J R; Odermatt, B; Schanz, U; Biedermann, B C; Seebach, J D (2011). Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation. Haematologica, 96(1):119-127.

[img]
Preview
PDF
1MB

Abstract

Background: The possibility that allogeneic hematopoietic stem cell transplantation performed across the ABO blood group-barrier is associated with an increase of graft-versus-host disease, in particular endothelial damage, has not been elucidated so far. For this reason, we investigated the level of endothelial cell chimerism after allogeneic hematopoietic stem cell transplantation in order to delineate the role of hematopoietic stem cells in endothelial replacement. Design and Methods: The frequency of donor-derived endothelial cells was analyzed in 52 hematopoietic stem cell transplantation recipients, in 22 normal skin biopsies, in 12 graft-versus-host disease affected skin samples, various tissues from 5 autopsies and 4 secondary solid tumors by ABH immunohistochemistry, XY fluorescence in situ hybridization and short tandem repeat analysis of laser captured endothelial cells. Results: Skin biopsies from two minor ABO-incompatible (i.e. O in A) transplanted patients showed 3.3% and 0.9% H antigen-positive donor-derived endothelial cells by ABH immunohistochemistry. Tumor biopsies from two recipients showed 1.2% and 2.5% donor-derived endothelial cells by combined immunohistochemistry/ fluorescence in situ hybridization. All other skin samples, heart, liver, bone-marrow, and tumor tissues failed to reveal donor-type endothelial cells up to several years after ABO-incompatible hematopoietic stem cell transplantation. Conclusions: Endothelial cell replacement by bone marrow-derived donor cells after allogeneic hematopoietic stem cell transplantation is a rare event. It does not seem to represent a major mechanism of physiological in vivo blood vessel formation, tumor neo-angiogenesis, and vascular repair after graft-versus-host disease episodes or acceptance of ABO-incompatible grafts.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Hematology
DDC:610 Medicine & health
Language:English
Date:January 2011
Deposited On:06 Jan 2011 14:49
Last Modified:27 Nov 2013 22:23
Publisher:Ferrata Storti Foundation
ISSN:0390-6078
Publisher DOI:10.3324/haematol.2010.030288
PubMed ID:20934999
Citations:Web of Science®. Times Cited: 5
Google Scholar™
Scopus®. Citation Count: 6

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page